Loading...

AVXL ANAVEX LIFE SCIENCES CORP Management Changes 8-K Filing

NVX

VXL

ANAVEX LIFE SCIENCES CORP

(AVXL)

2026 8-K

Management Change

CEO Termination Announcement

Application Withdrawal

Board Appointment

Financial Results Announced

Financial Results Announcement

Negative EMA Vote

Termination of Sales Agreement

Annual Meeting of Stockholders

Earnings Reports

Annual Meeting of Stockholders

Bylaws Amendment

Regulation FD Disclosure

External Links:

On April 30, 2026, Anavex Life Sciences terminated its CEO, Christopher Missling, for cause, and appointed Terrie Kellmeyer as Interim CEO starting May 4, 2026, with a base salary of $500,000 and a signing bonus of $150,000.

AI Assistant

ANAVEX LIFE SCIENCES CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.